Health Systems & Services Research | Transfusion Medicine
Manufacture of cellular therapies in a regulated environment – a ten year report
Pamela Dyson*, Judy Stevens, Gosia Badowicz, Michael Vo, Kerry Munro, Peter Harrsion, Ian Lewis
*Corresponding author: Pamela Dyson
Haematology Department, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia
F1000Posters 2011, 2: 1836 (slide presentation) [English]
Slide Presentation [6.73 MB]
Presented at
HAA-ISHAPD Joint Scientific Meeting 2011 ,
30 Oct - 2 Nov 2011, I:308
The facility was constructed to aid the manufacture of cellular therapies in a controlled environment. After 10 years in operation, a quality review was performed to enable future planning.
Event reports or “occurrence and deviation reports” were analysed and found to be an effective means of monitoring staff participation and engagement. The review showed continuous growth and development in quality of the system over time. It also enabled identification of areas of concern, and those of strength.
Areas of concern identified at review will be targeted as part of quality improvement. Increasing staff participation is a high priority, and effective means to achieve this will be investigated.
No relevant competing interests disclosed.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY-NC Creative Commons 3.0 License
